Number of Shares
17,717.00
Current Holdings Value*
$1.13 Mil
% of Portfolio
0.64%
Total Estimate Gain
$-26,752.67
% of Total Estimate Gain
-2.60%

LVIP JPMorgan Small Cap Core Fund's Halozyme Therapeutics Inc Holding Summary

As of 2025-03-31, LVIP JPMorgan Small Cap Core Fund held 17,717.00 shares of Halozyme Therapeutics Inc(HALO), totaling $1.13 Mil. This investment constitutes 0.64% of their stock portfolio, and LVIP JPMorgan Small Cap Core Fund now holds 0.01% of the outstanding Halozyme Therapeutics Inc(HALO) stock.

The initial trade took place in 2025Q1. And since then LVIP JPMorgan Small Cap Core Fund has made 1 purchases of HALO, at an average price of $58.09, for a total of 17,717.00 shares. Based on historical transaction data and HALO's current price of $56.58, LVIP JPMorgan Small Cap Core Fund's estimated gain on his HALO holdings is $-26,752.67, reflecting a -2.60% gain to date.

LVIP JPMorgan Small Cap Core Fund HALO ($56.58) Holding Chart

LVIP JPMorgan Small Cap Core Fund HALO ($56.58) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1